Notice of Special Interest (NOSI): Development of Functional Assay Sites to Evaluate Candidate -Omics Variants Associated with Heart, Lung, Blood, or Sleep Disease (R01, R41, R42, R43, R44)
Department of Health and Human Services ▸ National Institutes of Health ▸
Description
Research opportunity from NHLBI for academics and small businesses to develop and perform tests that validate disease-related genetic variants linked to heart, lung, blood, and sleep disorders. Emphasis is on comprehensive systems-level methods instead of targeting individual genes.
The NHLBI is seeking research applications from academic and small business entities to design and conduct biological functional assays for validating candidate disease variants associated with heart, lung, blood, and sleep disorders. The focus is on broad systems-level approaches rather than si…
Source
Grant ID
NOT-HL-23-066
Funding Source
Department of Health and Human Services ▸ National Institutes of Health ▸
Key Dates
Opportunity Released
January 31, 2023
Eligibility
The following categories of applicants are invited to apply:
- Small Businesses
Similar opportunities
- Notice of Funding Opportunity (NOFO) for Early Stage Translational Support for Heart, Lung, Blood, and Sleep (HLBS) Diseases and Disorders
- Notice of Funding Opportunity (NOFO) for Early Stage Translational Support for Heart, Lung, Blood, and Sleep (HLBS) Diseases and Disorders
- Notice of Funding Opportunity Purpose
- Notice of Funding Opportunity (NOFO) for Early Stage Translational Support for Heart, Lung, Blood, and Sleep (HLBS) Diseases and Disorders
- NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)